Mechanistically, the anti-atherogenic effects of CTRP4 were mediated by the engagement and inhibition of RAGE and TLR4.<h4>Conclusions</h4>Decreased CTRP4 levels in serum and epicardial adipose tissue are associated with CAD in patients. Here, C1QTNF4 is linked to coronary artery disorder.